
1. Technology overview
V5med Inc. is a smart healthcare company headquartered in the Hsinchu Science Industrial Park, Hsinchu City, Taiwan. It was set up as a smart-medicine startup backed by its parent company V5 Technologies, which has experience in high-speed imaging, deep learning and computer vision.
The lead product is V5med Lung AI (model V5-MED-LU01), a computer-aided detection software for lung imaging that reads low-dose CT scans and flags suspicious nodules. The V5 Smart Medical Platform (AI Conductor) receives scans from several AI modules and presents combined findings in the physician workflow. Partner hospitals include Taichung Veterans General Hospital.
2. Highlighted features & specifications
- Lung nodule detection: computer-aided detection on low-dose CT lung images.
- Lung imaging reading assistance: flags suspicious lesions to help radiologists reduce missed findings.
- AI Conductor: platform that collects results from several AI modules and runs in real time.
- Coronary artery imaging: AI reading assistant developed with Taichung Veterans General Hospital.
- Smart health checkup: AI-assisted checkup project with the same hospital.
- Smart nursing: AI nursing solution built with Kuang Tien General Hospital.
3. Potential application
Vietnamese hospitals running lung cancer screening programs can use the nodule reader as a second reader on LDCT. Health checkup centers can add AI lung and coronary reading to executive packages. Hospital groups can use the platform to consolidate several AI tools in one viewer.
4. Benefits
Supports earlier detection of lung nodules on low-dose CT screening. Holds a Taiwan Class II medical device license (end of 2022) and a US FDA 510(k) clearance for the lung nodule system, per company news. A platform layer lets hospitals combine several AI modules in one reading workflow. Co-development with a hospital shows clinical workflow fit.
5. Market trends & opportunities
Low-dose CT screening for lung cancer is expanding across Asia, which raises radiologist workload and demand for nodule detection software. A company article states that hospitals in Vietnam have decided to place orders and that Indonesia, Thailand, Malaysia and the Philippines are in evaluation or planning stages.
6. Other information
Headquartered in Hsinchu Science Industrial Park, Taiwan. Parent company is V5 Technologies. Company news reports a Japan device certification obtained with help from the Marubeni Group. Founding year is not stated on the site.
One platform connecting startups, corporations, research institutions, regions and investors











Playbook & Handbook · February 6, 2026
Winning Accelerator Playbook 2026 by BambuUP
RETAIL E-COMMERCE: AI AND REAL-TIME DATA ARE TRANSFORMING HOW RETAIL BUSINESSES OPERATE








































